ST
Savita Tiwari
About Savita Tiwari
Data last updated:
Savita Tiwari is a Director at Scynor Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Scynor Pharmaceuticals Private Limited reported revenue of ₹32.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Scynor Pharmaceuticals Private Limited U24239MP2021PTC054905 | Director | 12 Feb 2021 | 2021 | ₹32.2 Lakh (FY 2024) | Active |
Board colleagues of Savita Tiwari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepak Kumar Tiwari | 09065972 | Scynor Pharmaceuticals Private Limited | Director |
| Phul Kumari Tiwari | 09065973 | Scynor Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Savita Tiwari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Savita Tiwari
Savita Tiwari currently holds 1 directorship: Scynor Pharmaceuticals Private Limited (Director, since 12 Feb 2021, revenue ₹32.2 Lakh (FY 2024)).
Savita Tiwari was first appointed on 12 Feb 2021 as Director at Scynor Pharmaceuticals Private Limited.
The current boards of Savita Tiwari's companies include Deepak Kumar Tiwari (Scynor Pharmaceuticals Private Limited), Phul Kumari Tiwari (Scynor Pharmaceuticals Private Limited).